| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |